Oren J. Becher

8.5k total citations · 1 hit paper
88 papers, 4.6k citations indexed

About

Oren J. Becher is a scholar working on Genetics, Molecular Biology and Neurology. According to data from OpenAlex, Oren J. Becher has authored 88 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Genetics, 43 papers in Molecular Biology and 18 papers in Neurology. Recurrent topics in Oren J. Becher's work include Glioma Diagnosis and Treatment (62 papers), Neuroblastoma Research and Treatments (16 papers) and Chromatin Remodeling and Cancer (13 papers). Oren J. Becher is often cited by papers focused on Glioma Diagnosis and Treatment (62 papers), Neuroblastoma Research and Treatments (16 papers) and Chromatin Remodeling and Cancer (13 papers). Oren J. Becher collaborates with scholars based in United States, Canada and Spain. Oren J. Becher's co-authors include Dolores Hambardzumyan, Eric C. Holland, Francisco J. Cordero, C. David Allis, Laura A. Banaszynski, Manuel M. Müller, Shu Lin, Tom W. Muir, Peter W. Lewis and Benjamin A. Garcia and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Oren J. Becher

82 papers receiving 4.5k citations

Hit Papers

Inhibition of PRC2 Activity by a Gain-of-Function H3 Muta... 2013 2026 2017 2021 2013 250 500 750

Peers

Oren J. Becher
Tobey J. MacDonald United States
Yoon-Jae Cho United States
Anja Smits Sweden
Maryam Fouladi United States
Alberto Broniscer United States
Shin Jung South Korea
Maryam Rahman United States
Tobey J. MacDonald United States
Oren J. Becher
Citations per year, relative to Oren J. Becher Oren J. Becher (= 1×) peers Tobey J. MacDonald

Countries citing papers authored by Oren J. Becher

Since Specialization
Citations

This map shows the geographic impact of Oren J. Becher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oren J. Becher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oren J. Becher more than expected).

Fields of papers citing papers by Oren J. Becher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oren J. Becher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oren J. Becher. The network helps show where Oren J. Becher may publish in the future.

Co-authorship network of co-authors of Oren J. Becher

This figure shows the co-authorship network connecting the top 25 collaborators of Oren J. Becher. A scholar is included among the top collaborators of Oren J. Becher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oren J. Becher. Oren J. Becher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Jiabo, Cheryl L. Olson, David P. Sullivan, et al.. (2025). A clinically relevant model and method to study necrosis as a driving force in glioma restructuring and progression. Proceedings of the National Academy of Sciences. 122(7). e2416024122–e2416024122. 1 indexed citations
2.
Ross, James, Gonzalo Piñero, John DeSisto, et al.. (2024). Microglia and monocyte-derived macrophages drive progression of pediatric high-grade gliomas and are transcriptionally shaped by histone mutations. Immunity. 57(11). 2669–2687.e6. 9 indexed citations
3.
Watanabe, Jun, Matthew R. Clutter, Takahiro Sasaki, et al.. (2024). BET bromodomain inhibition potentiates radiosensitivity in models of H3K27-altered diffuse midline glioma. Journal of Clinical Investigation. 134(13). 4 indexed citations
4.
Galat, Yekaterina, Yuchen Du, Xiao‐Nan Li, et al.. (2023). In vitro vascular differentiation system efficiently produces natural killer cells for cancer immunotherapies. OncoImmunology. 12(1). 2240670–2240670. 6 indexed citations
5.
Tomita, Yusuke, Yosuke Shimazu, Agila Somasundaram, et al.. (2022). A novel mouse model of diffuse midline glioma initiated in neonatal oligodendrocyte progenitor cells highlights cell‐of‐origin dependent effects of H3K27M. Glia. 70(9). 1681–1698. 18 indexed citations
6.
Siddaway, Robert, Jyothishmathi Swaminathan, Scott Ryall, et al.. (2022). Splicing is an alternate oncogenic pathway activation mechanism in glioma. Nature Communications. 13(1). 588–588. 26 indexed citations
7.
Somasundaram, Agila, et al.. (2021). Prenatal overexpression of platelet‐derived growth factor receptor A results in central nervous system hypomyelination. Brain and Behavior. 11(10). e2332–e2332. 12 indexed citations
8.
Crabtree, Donna, Nerissa T. Williams, Lixia Luo, et al.. (2021). Radiosensitizing the Vasculature of Primary Brainstem Gliomas Fails to Improve Tumor Response to Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 112(3). 771–779. 6 indexed citations
9.
Tomita, Yusuke, Yoshihiro Tanaka, Nozomu Takata, et al.. (2021). Fifteen-year trends and differences in mortality rates across sex, age, and race/ethnicity in patients with brainstem tumors. Neuro-Oncology Advances. 3(1). vdab137–vdab137. 3 indexed citations
10.
Crabtree, Donna, Nerissa T. Williams, Lixia Luo, et al.. (2020). Tumor genotype dictates radiosensitization after Atm deletion in primary brainstem glioma models. Journal of Clinical Investigation. 131(1). 26 indexed citations
11.
Cordero, Francisco J., Zhiqing Huang, Carole Grenier, et al.. (2017). Histone H3.3K27M Represses p16 to Accelerate Gliomagenesis in a Murine Model of DIPG. Molecular Cancer Research. 15(9). 1243–1254. 97 indexed citations
12.
Mittapalli, Rajendar K., Karen E. Parrish, Donna Crabtree, et al.. (2016). ABCG2 and ABCB1 Limit the Efficacy of Dasatinib in a PDGF-B–Driven Brainstem Glioma Model. Molecular Cancer Therapeutics. 15(5). 819–829. 51 indexed citations
13.
Buczkowicz, Pawel, Ute Bartels, Éric Bouffet, Oren J. Becher, & Cynthia Hawkins. (2014). Histopathological spectrum of paediatric diffuse intrinsic pontine glioma: diagnostic and therapeutic implications. Acta Neuropathologica. 128(4). 573–581. 228 indexed citations
14.
Sturm, Dominik, Sebastian Bender, David Jones, et al.. (2014). Paediatric and adult glioblastoma: multiform (epi)genomic culprits emerge. Nature reviews. Cancer. 14(2). 92–107. 402 indexed citations
15.
Lewis, Peter W., Manuel M. Müller, Francisco J. Cordero, et al.. (2013). Inhibition of PRC2 Activity by a Gain-of-Function H3 Mutation Found in Pediatric Glioblastoma. Science. 340(6134). 857–861. 898 indexed citations breakdown →
17.
Becher, Oren J., Dolores Hambardzumyan, Karim Y. Helmy, et al.. (2010). Preclinical Evaluation of Radiation and Perifosine in a Genetically and Histologically Accurate Model of Brainstem Glioma. Cancer Research. 70(6). 2548–2557. 130 indexed citations
18.
Hambardzumyan, Dolores, et al.. (2009). Sonic Hedgehog Pathway Activation Is Induced by Acute Brain Injury and Regulated by Injury-Related Inflammation. Journal of Neuroscience. 29(33). 10299–10308. 167 indexed citations
19.
Becher, Oren J., Dolores Hambardzumyan, Elena I. Fomchenko, et al.. (2008). Gli Activity Correlates with Tumor Grade in Platelet-Derived Growth Factor–Induced Gliomas. Cancer Research. 68(7). 2241–2249. 151 indexed citations
20.
Hambardzumyan, Dolores, Oren J. Becher, & Eric C. Holland. (2008). Cancer stem cells and survival pathways. Cell Cycle. 7(10). 1371–1378. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026